In light of the COVID-19 pandemic and its impact on the MS community, please know the Multiple Sclerosis Association of American (MSAA) has [...]
Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of [...]
New 6-Year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in [...]
Elaine Whitaker died unexpectedly and peacefully on March 31, 2020. Dr. Whitaker was born in Oklahoma City, OK, and grew up in Little Rock, [...]
(Hackensack, NJ, April 2020) --The Consortium of Multiple Sclerosis Centers (CMSC) and the National Multiple Sclerosis Society have [...]
The Plegridy (peginterferon beta-1a) Prescribing Information and the Avonex (interferon beta-1a) Prescribing Information was updated in the [...]
(Hackensack, NJ, March 2020) --The Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting scheduled for May 27-30, 2020 in [...]
